158 related articles for article (PubMed ID: 38156392)
21. Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.
Abdulnoor M; Eshaghi A; Perusini SJ; Broukhanski G; Corbeil A; Cronin K; Fittipaldi N; Forbes JD; Guthrie JL; Kus JV; Li Y; Majury A; Mallo GV; Mazzulli T; Melano RG; Olsha R; Sullivan A; Tran V; Patel SN; Allen VG; Gubbay JB
Microbiol Spectr; 2022 Feb; 10(1):e0068121. PubMed ID: 35170989
[TBL] [Abstract][Full Text] [Related]
22. A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2.
Carbo EC; Mourik K; Boers SA; Munnink BO; Nieuwenhuijse D; Jonges M; Welkers MRA; Matamoros S; van Harinxma Thoe Slooten J; Kraakman MEM; Karelioti E; van der Meer D; Veldkamp KE; Kroes ACM; Sidorov I; de Vries JJC
Eur J Clin Microbiol Infect Dis; 2023 Jun; 42(6):701-713. PubMed ID: 37017810
[TBL] [Abstract][Full Text] [Related]
23. Local monitoring of SARS-CoV-2 variants in two large California counties in 2021.
Kojima N; Khorosheva E; Lopez L; Hanewich-Hollatz M; Ignacio-Espinoza JC; Brobeck M; Chen J; Geluz M; Hess V; Quasem S; Sandhu N; Salfati E; Shacreaw M; Way G; Xie Z; Slepnev V; Klausner JD
Sci Rep; 2022 Oct; 12(1):17046. PubMed ID: 36221029
[TBL] [Abstract][Full Text] [Related]
24. Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance.
Zelyas N; Pabbaraju K; Croxen MA; Lynch T; Buss E; Murphy SA; Shokoples S; Wong A; Kanji JN; Tipples G
Microbiol Spectr; 2021 Sep; 9(1):e0031521. PubMed ID: 34378966
[TBL] [Abstract][Full Text] [Related]
25. Inactivation and Recovery of High Quality RNA From Positive SARS-CoV-2 Rapid Antigen Tests Suitable for Whole Virus Genome Sequencing.
Macori G; Russell T; Barry G; McCarthy SC; Koolman L; Wall P; Sammin D; Mulcahy G; Fanning S
Front Public Health; 2022; 10():863862. PubMed ID: 35592078
[TBL] [Abstract][Full Text] [Related]
26. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
[TBL] [Abstract][Full Text] [Related]
27. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
[TBL] [Abstract][Full Text] [Related]
28. Genetic Surveillance of Five SARS-CoV-2 Clinical Samples in Henan Province Using Nanopore Sequencing.
Wang Y; Chen D; Zhu C; Zhao Z; Gao S; Gou J; Guo Y; Kong X
Front Immunol; 2022; 13():814806. PubMed ID: 35444655
[TBL] [Abstract][Full Text] [Related]
29. Identification of Genomic Variants of SARS-CoV-2 Using Nanopore Sequencing.
Capraru ID; Romanescu M; Anghel FM; Oancea C; Marian C; Sirbu IO; Chis AR; Ciordas PD
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557043
[No Abstract] [Full Text] [Related]
30. Sequencing of SARS-CoV-2 in local transmission cases through Oxford Nanopore MinION platform from Karachi Pakistan.
Mukry SN; Ahmed S; Raza Bukhari A; Shahni A; Sufaida G; Naz A; Shamsi TS
J Infect Dev Ctries; 2021 Oct; 15(10):1376-1383. PubMed ID: 34780358
[TBL] [Abstract][Full Text] [Related]
31. Portable RT-PCR and MinION Nanopore Sequencing as a Proof-of-Concept SARS-CoV-2 Biosurveillance in Wastewater.
Pavlyuk OM; Engler J; Strapple C; Stamps BW; Dietrich MT
MSMR; 2023 May; 30(5):9-14. PubMed ID: 37535262
[TBL] [Abstract][Full Text] [Related]
32. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
Borillo GA; Kagan RM; Marlowe EM
Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
[TBL] [Abstract][Full Text] [Related]
33. Surveillance of SARS-CoV-2 Genetic Variants in the Polish Armed Forces Using Whole Genome Sequencing Analysis.
Skuza K; Rutyna P; Krzowski L; Rabalski L; Lepionka T
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834302
[TBL] [Abstract][Full Text] [Related]
34. Whole-genome sequencing of SARS-CoV-2 in Uganda: implementation of the low-cost ARTIC protocol in resource-limited settings.
Mboowa G; Mwesigwa S; Kateete D; Wayengera M; Nasinghe E; Katagirya E; Katabazi AF; Kigozi E; Kirimunda S; Kamulegeya R; Kabahita JM; Luutu MN; Nabisubi P; Kanyerezi S; Bagaya BS; Joloba ML
F1000Res; 2021; 10():598. PubMed ID: 34457243
[No Abstract] [Full Text] [Related]
35. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.
Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW
Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
medRxiv; 2021 Dec; ():. PubMed ID: 34909794
[TBL] [Abstract][Full Text] [Related]
37. Genomic surveillance of severe acute respiratory syndrome coronavirus 2 in Burundi, from May 2021 to January 2022.
Nduwimana C; Nzoyikorera N; Ndihokubwayo A; Ihorimbere T; Nibogora C; Ndoreraho A; Hajayandi O; Bizimana JC; Diawara I; Niyonizigiye D; Nyandwi J
BMC Genomics; 2023 Jun; 24(1):312. PubMed ID: 37301830
[TBL] [Abstract][Full Text] [Related]
38. Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania.
Mziray SR; van Zwetselaar M; Kayuki CC; Mbelele PM; Makubi AN; Magesa AS; Kisonga RM; Sonda TB; Kibiki GS; Githinji G; Heysell SK; Chilongola JO; Mpagama SG
Front Med (Lausanne); 2022; 9():1034682. PubMed ID: 36687433
[TBL] [Abstract][Full Text] [Related]
39. Detecting SARS-CoV-2 Omicron B.1.1.529 Variant in Wastewater Samples by Using Nanopore Sequencing.
Rasmussen LD; Richter SR; Midgley SE; Franck KT
Emerg Infect Dis; 2022 Jun; 28(6):1296-1298. PubMed ID: 35362410
[TBL] [Abstract][Full Text] [Related]
40. Rapid Detection of the Omicron (B.1.1.529) SARS-CoV-2 Variant Using a COVID-19 Diagnostic PCR Assay.
Ippoliti C; De Maio F; Santarelli G; Marchetti S; Vella A; Santangelo R; Sanguinetti M; Posteraro B
Microbiol Spectr; 2022 Aug; 10(4):e0099022. PubMed ID: 35863025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
